XML 110 R101.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options Outstanding, Weighted-Average Remaining Contractual Term 4 years 10 months 24 days    
Options Outstanding, Aggregate Intrinsic Value $ 52.0    
Maximum number of shares reserved for grant awards under the plan 13,900,000    
Number of shares counted against reserve for determining number of shares of stock available for grant under the Plan for each option 1    
Number of shares counted against reserve for each share of stock granted, other than option or stock appreciation right 1.61    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 7,200,000    
Maximum number of underlying shares that may be granted to a participant in any one calendar year 5,000,000.0    
Period over which maximum award grant per participant applies 1 year    
Stock options, shares      
Exercised (in shares) (629,186) (462,647) (90,938)
Selected amounts pertaining to stock option exercises:      
Issuances of common stock under employee stock plans $ 19.0 $ 12.0 $ 1.0
Stock-based compensation costs      
Stock-based compensation expense 28.0 21.0 17.0
Income tax benefit (6.0) (4.0) (6.0)
Stock-based compensation expense, net of income taxes $ 22.0 $ 17.0 $ 11.0
Options Exercisable, Weighted-Average Remaining Contractual Term 4 years 8 months 12 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 43.0    
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contractual life 10 years    
Weighted-average assumptions:      
Weighted-average expected volatility (as a percent)     40.00%
Expected term of stock options     4 years 3 months 18 days
Risk-free interest rate (as a percent)     1.90%
Weighted-average expected dividend yield (as a percent)     3.90%
Weighted-average grant date fair value per share of options granted (in dollars per share)     $ 7.66
Stock options, shares      
Outstanding at the beginning of the period (in shares) 5,784,100    
Exercised (in shares) (629,186)    
Forfeited (in shares) (54,045)    
Expired (in shares) (40,977)    
Outstanding at the end of the period (in shares) 5,059,892 5,784,100  
Exercisable balance at the end of the period (in shares) 4,518,530    
Stock option activity, weighted-average exercise price      
Outstanding at the beginning of the period, Weighted-Average Exercise Price (in dollars per share) $ 38.79    
Exercised, Weighted-Average Exercise Price (in dollars per share) 28.89    
Forfeited, Weighted-Average Exercise Price (in dollars per share) 37.11    
Expired, Weighted-Average Grant Date Fair Value (in dollars per share) 58.78    
Outstanding at the end of the period, Weighted-Average Exercise Price (in dollars per share) 39.88 $ 38.79  
Exercisable balance at the end of the period, Weighted-Average Exercise Price (in dollars per share) $ 40.94    
Selected amounts pertaining to stock option exercises:      
Issuances of common stock under employee stock plans $ 18.0 $ 12.0 $ 1.0
Actual tax benefit realized from stock option exercises 3.0 2.0 1.0
Pre-tax intrinsic value of stock options exercised 12.0 $ 10.0 $ 2.0
Stock-based compensation costs      
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 1.0    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 2 months 12 days    
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 36,567 37,870  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 41.84 $ 40.40  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 36,567    
Selected amounts pertaining to stock option exercises:      
Vesting period 3 years    
Restricted stock activity, weighted-average exercise price      
Granted, Weighted-Average Grant Date Fair Value (in dollars per share) $ 41.84 $ 40.40 $ 27.31
Stock-based compensation costs      
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 14.0    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 1 year 7 months 6 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (37,870)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 40.40    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 0    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 0    
Restricted Stock | Non-management member of Board of Directors      
Selected amounts pertaining to stock option exercises:      
Vesting period 1 year    
Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 693,960 569,807  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 40.14 $ 38.79  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 356,110    
Restricted stock activity, weighted-average exercise price      
Granted, Weighted-Average Grant Date Fair Value (in dollars per share) $ 41.94 $ 43.09 31.20
Stock-based compensation costs      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (196,611)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 40.26    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (35,346)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 41.04    
Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 304,834 197,937  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 44.42 $ 43.64  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 179,876    
Restricted stock activity, weighted-average exercise price      
Granted, Weighted-Average Grant Date Fair Value (in dollars per share) $ 43.09 $ 44.59 $ 45.37
Stock-based compensation costs      
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 9.0    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 1 year 8 months 12 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (59,407)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 40.62    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (13,572)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 44.31